Abstract:BACKGROUND:Studies have testified that nano-ultrasound contrast agents have a strong permeability, making it possible to image the targeted tissues outside blood vessels and overcome the limitation that micron contrast agents are only available for the blood pool imaging. OBJECTIVE:To construct the folate-modified nanoparticles targeting breast cancer as ultrasound contrast agents, as wel as to observe their ability to specifical y bind to cel s and imaging effect in vitro. METHODS:Both contrast agents, pegylated lactic acid-glycolic acid copolymer wrapping liquid fluorocarbon formed nanoparticles (mPP/PFOB) and folate modified pegylated lactic acid-glycolic acid wrapping liquid fluorocarbon formed nanoparticles (mPPF/PFOB), were constructed by phacoemulsification-evaporation method. (1)Biocompatibility detection:HFF-1 and MCF-7 cel s in the logarithmic phase were cultivated with various concentrations (0, 0.005, 0.01, 0.02, 0.05, 0.1, 0.2 and 1 g/L) of mPP/PFOB or mPPF/PFOB for 24 hours respectively, and then the cel viability was measured. (2)Targeting ability detection in vitro:HFF-1 and MCF-7 cel s in the logarithmic phase were divided into three groups. Cy5-labled mPP/PFOB and mPPF/PFOB were added into groups A and B, respectively;the cel s in group C were pretreated with folate for 2 hours, and sequential y Cy5-labled mPPF/PFOB was added into group C. Fluorescence intensity was detected by flow cytometry after 0.5 hours of culture. The distribution of contrast agents in cel s was observed using confocal microscopy after 20 minutes of culture. (3)Ultrasound imaging in vitro:there were three groups:saline was as group A;the suspension of saline and mPPF/PFOB nanoparticles was prepared as group B;MCF-7 cel s were resuspended with the mixture of saline and mPPF/PFOB nanoparticles to prepare the suspension of nanoparticles and cel s as group C. In each group, the suspension was added into latex gloves, that were then tightened and immersed in water. Final y, the ultrasound was use to detect the ultrasound imaging effect in vitro. RESULTS AND CONCLUSION:Neither nanoparticles were with significant cytotoxicity. The flow cytometry showed that the mean fluorescence intensity in MCF-7 cel s of group B was significantly higher than that of groups A and C. But there were no significant differences in the mean fluorescence intensity in HFF-1 cel s among the three groups. It was observed that mPPF/PFOB mainly gathered around the MCF-7 cel membrane, while mPP/PFOB randomly distributed in the cytoplasm. After mPPF/PFOB binding to MCF-7 cel s, they could enhance ultrasound echo in vitro. These findings indicate that the targeted nanoparticles mPPF/PFOB have good biocompatibility and can specifical y bind to breast cancer MCF-7 cel s in vitro and enhance the imaging capability.

Experimental study on preparation and in vivo enhanced effect of a novel lipid perfluorooctylbromide nanoparticles

Experimental Study of Lipid Perfluorooctylbromide Nanoparticles Ultrasound Contrast Agent in Enhanced Computed Tomography of Rats

Fe3O4-loaded Lipid Perfluorooctylbromide Nanoparticles As Ultrasound Contrast Agents

Perfluorooctyl Bromide Traces Self-Assembled with Polymeric Nanovesicles for Blood Pool Ultrasound Imaging

Preparation and ultrasonic imaging of PFOB-Ioaded polymeric nanomicelle and nanovesicle

Characteristics and Enhancement Effect of A Self-made Nano-lipid Ultrasound-enhanced Contrast:In Vitro and in Vivo Experimental Study

Superparamagnetic Perfluorooctylbromide Nanoparticles As A Multimodal Contrast Agent for Us, Mr, and Ct Imaging

Carboxyl of Poly(D,L-lactide-co-glycolide) Nanoparticles of Perfluorooctyl Bromide for Ultrasonic Imaging of Tumor

Preparation and in Vitro-Targeted Study of Liquid Perfluorocarbons-Filled Nanocapsules Ultrasound Contrast Agent

Preparation and Characterization of Novel Perfluorooctyl Bromide Nanoparticle As Ultrasound Contrast Agent Via Layer-by-Layer Self-Assembly for Folate-Receptor-Mediated Tumor Imaging.

Ultrasound-Triggered Phase Transition Sensitive Magnetic Fluorescent Nanodroplets As a Multimodal Imaging Contrast Agent in Rat and Mouse Model

High-fidelity Imaging of Fatty Liver in Vivo with a Fluorescent and Photoacoustic Dual-Mode Probe by Taking Advantage of the Liver “first Pass Effect”

Preparation of Molecular Polymer Ultrasound Contrast Agents with Liquid Perfluorocarbons and in Vitro Experiment

Lactoferrin-Conjugated Polylactic Acid Nanobubbles Encapsulated Perfluoropentane as a Contrast Agent for Ultrasound/Magnetic Resonance Dual-Modality Imaging

Anti-Biofouling Polymer-Decorated Lutetium-Based Nanoparticulate Contrast Agents For In Vivo High-Resolution Trimodal Imaging

Progress in Molecular Development and Therapeutic Effect of Perfluorooctylbromide Ultrasound Contrast Agent

Construction of folate-modified nanoparticles as ultrasound contrast agent targeting breast cancer

Phase‐shifted pentafluorobutane nanoparticles for ultrasound imaging and ultrasound‐mediated hypoxia modulation

Folate Receptor-Targeted Ultrasonic PFOB Nanoparticles: Synthesis, Characterization and Application in Tumor-Targeted Imaging

Heat-sensitive liquid perfluorocarbons nanoparticles for acoustic vaporation and in vitro ultrasound imaging

Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.